Literature DB >> 9122226

Pluripotent hemopoietic stem cells are c-kit<low.

H Doi1, M Inaba, Y Yamamoto, S Taketani, S I Mori, A Sugihara, H Ogata, J Toki, H Hisha, K Inaba, S Sogo, M Adachi, T Matsuda, R A Good, S Ikehara.   

Abstract

Pluripotent hemopoietic stem cells (P-HSCs) were thought to be c-kit+, but recent reports indicate that they are c-kit(low). In the present report, we provide evidence using Ly5 congenic mice that P-HSCs are c-kit(<low). Lineage-negative (Lin-)/CD71- cells among bone marrow cells (BMCs) from C57BL/6 Ly5.1 mice were separated into major histocompatibility complex class I(high) (class I(high))/c-kit(low) and class I(high)/ c-kit(<low) populations. Each population (500 cells) was transplanted into lethally (9.0 Gy) irradiated C57BL/6 Ly5.2 congenic mice along with Ly5.2 (2 x 10(5)) compromised cells. Donor-derived Ly5.1+ cells were detected 6 months after transplantation in primary recipients reconstituted with either class I(high)/c-kit(low) or class I(high)/c-kit(<low) cells. BMCs (1 x 10(6)) from the primary recipients were further transplanted into secondary recipients (Ly5.2 mice) to assess their long term repopulating activity. Six months after bone marrow transplantation, Ly5.1+ cells in all lineages were detected only in secondary recipients that had been given BMCs from the primary recipients reconstituted with class I(high)/c-kit(<low) cells but not in cells that were class I(high)/c-kit(low). When the BMCs (1 x 10(6)) of these secondary recipients were further transplanted into tertiary recipients, all tertiary recipients that had been given BMCs from the secondary recipients originally reconstituted with Lin-/CD71-/class I(high)/c-kit(low) cells died within 10 days whereas all six tertiary recipients originally reconstituted with Lin-/CD71-/class I(high)/c-kit(<low) cells showed donor (Ly5.1+)-derived cells in their peripheral blood. In the single tertiary recipient that was killed, donor-derived T cells, B cells, macrophages, and granulocytes also were detected in several major hematolymphoid organs. The remaining five mice continue to survive more than 6 months after the tertiary bone marrow transplantation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9122226      PMCID: PMC20119          DOI: 10.1073/pnas.94.6.2513

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus.

Authors:  E Huang; K Nocka; D R Beier; T Y Chu; J Buck; H W Lahm; D Wellner; P Leder; P Besmer
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

Review 2.  Heterogeneity of hematopoietic stem cells.

Authors:  N Uchida; W H Fleming; E J Alpern; I L Weissman
Journal:  Curr Opin Immunol       Date:  1993-04       Impact factor: 7.486

3.  Enhancement of murine blast cell colony formation in culture by recombinant rat stem cell factor, ligand for c-kit.

Authors:  K Tsuji; K M Zsebo; M Ogawa
Journal:  Blood       Date:  1991-09-01       Impact factor: 22.113

4.  Stem cell factor induces proliferation and differentiation of highly enriched murine hematopoietic cells.

Authors:  G Migliaccio; A R Migliaccio; J Valinsky; K Langley; K Zsebo; J W Visser; J W Adamson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

5.  Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages.

Authors:  I K McNiece; K E Langley; K M Zsebo
Journal:  Exp Hematol       Date:  1991-03       Impact factor: 3.084

6.  The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype.

Authors:  S J Morrison; I L Weissman
Journal:  Immunity       Date:  1994-11       Impact factor: 31.745

7.  Purification and characterization of mouse hematopoietic stem cells.

Authors:  G J Spangrude; S Heimfeld; I L Weissman
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

8.  Human fetal bone marrow early progenitors for T, B, and myeloid cells are found exclusively in the population expressing high levels of CD34.

Authors:  D DiGiusto; S Chen; J Combs; S Webb; R Namikawa; A Tsukamoto; B P Chen; A H Galy
Journal:  Blood       Date:  1994-07-15       Impact factor: 22.113

9.  Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7.

Authors:  D Orlic; S Anderson; L G Biesecker; B P Sorrentino; D M Bodine
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

10.  Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow.

Authors:  R R Hardy; C E Carmack; S A Shinton; J D Kemp; K Hayakawa
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more
  9 in total

1.  Identification of progenitor cells in long-term spleen stromal cultures that produce immature dendritic cells.

Authors:  H L Wilson; K Ni; H C O'Neill
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

2.  A novel stem-cell population in adult liver with potent hematopoietic-reconstitution activity.

Authors:  Darrell N Kotton; Attila J Fabian; Richard C Mulligan
Journal:  Blood       Date:  2005-05-03       Impact factor: 22.113

3.  Green fluorescent protein transgene driven by Kit regulatory sequences is expressed in hematopoietic stem cells.

Authors:  Francesco Cerisoli; Letizia Cassinelli; Giuseppe Lamorte; Stefania Citterio; Francesca Bertolotti; Maria Cristina Magli; Sergio Ottolenghi
Journal:  Haematologica       Date:  2009-01-30       Impact factor: 9.941

4.  Differential regulation of the human and murine CD34 genes in hematopoietic stem cells.

Authors:  Yutaka Okuno; Hiromi Iwasaki; Claudia S Huettner; Hanna S Radomska; David A Gonzalez; Daniel G Tenen; Koichi Akashi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

5.  Purified hematopoietic stem cells without facilitating cells can repopulate fully allogeneic recipients across entire major histocompatibility complex transplantation barrier in mice.

Authors:  B y Wang; N S El-Badri; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

Review 6.  Pathologic thrombopoiesis of rheumatoid arthritis.

Authors:  Ihsan Ertenli; Sedat Kiraz; M Akif Oztürk; Ibrahim c Haznedaroğlu; Ismail Celik; Meral Calgüneri
Journal:  Rheumatol Int       Date:  2003-02-11       Impact factor: 2.631

7.  Clonal expansion capacity defines two consecutive developmental stages of long-term hematopoietic stem cells.

Authors:  Tatyana Grinenko; Kathrin Arndt; Melanie Portz; Nicole Mende; Marko Günther; Kadriye Nehir Cosgun; Dimitra Alexopoulou; Naharajan Lakshmanaperumal; Ian Henry; Andreas Dahl; Claudia Waskow
Journal:  J Exp Med       Date:  2014-01-20       Impact factor: 14.307

8.  Altered Erythro-Myeloid Progenitor Cells Are Highly Expanded in Intensively Regenerating Hematopoiesis.

Authors:  Kateřina Faltusová; Chia-Ling Chen; Tomáš Heizer; Martin Báječný; Katarina Szikszai; Petr Páral; Filipp Savvulidi; Nicol Renešová; Emanuel Nečas
Journal:  Front Cell Dev Biol       Date:  2020-02-25

9.  Bone morphogenetic protein 4 modulates c-Kit expression and differentiation potential in murine embryonic aorta-gonad-mesonephros haematopoiesis in vitro.

Authors:  Caroline J Marshall; Joanna C Sinclair; Adrian J Thrasher; Christine Kinnon
Journal:  Br J Haematol       Date:  2007-10       Impact factor: 6.998

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.